Publication & Citation Trends
Publications
0 total
P017 Abemaciclib + endocrine therapy (ET) for HR+, HER2-, node-positive, high-risk EBC: results from a pre-planned monarchE overall survival (OS) interim analysis (IA), including 4-year efficacy outcomes
Cited by 0
Semantic Scholar
Abstract GS1-09: Abemaciclib plus endocrine therapy for HR+, HER2-, node-positive, high-risk early breast cancer: results from a pre-planned monarchE overall survival interim analysis, including 4-year efficacy outcomes
Cited by 2
Semantic Scholar
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial. OA
Cited by 372
Semantic Scholar
Abstract PD2-01: High Ki-67 as a biomarker for identifying patients with high risk early breast cancer treated in monarchE
Cited by 21
Semantic Scholar
Research Topics
Advanced Breast Cancer Therapies
(6)
Breast Cancer Treatment Studies
(4)
HER2/EGFR in Cancer Research
(4)
Cancer-related Molecular Pathways
(3)
Ovarian cancer diagnosis and treatment
(1)
Affiliations
Hospital General de México
National Cancer Center